ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2009;88:958-964. doi:10.1016/j.athoracsur.2009.05.075
© 2009 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Pasquale Ferraro
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Sugita, M.
Right arrow Articles by Ferraro, P.
PubMed
Right arrow Articles by Sugita, M.
Right arrow Articles by Ferraro, P.
Related Collections
Right arrow Lung - transplantation
Right arrowRelated Article


Original Articles: General Thoracic

Pharmacologic Modulation of Alveolar Liquid Clearance in Transplanted Lungs by Phentolamine and FK506

Makoto Sugita, MD, PhD, Yves Berthiaume, MD, MS*, Michael VanSpall, MD, André Dagenais, PhD, Pasquale Ferraro, MD

Centre de Recherche, CHUM, and Departments of Medicine and Surgery, University of Montreal, Montreal, Quebec, Canada

Accepted for publication May 20, 2009.

* Address correspondence to Dr Berthiaume, Centre de Recherche, CHUM-Hôtel-Dieu, 3850 St-Urbain, Montréal, Québec, H2W 1T7, Canada (Email: yves.berthiaume{at}umontreal.ca).

Background: The lung's capacity to clear alveolar fluid can determine the severity of the edema seen after transplantation. We recently observed that alveolar liquid clearance was decreased in transplanted lungs. This study evaluates the ability of phentolamine and FK506 to modulate the severity of lung injury and the decline in alveolar liquid clearance after transplantation.

Methods: A canine orthotopic single-lung transplantation model was used. The lungs were preserved with a low-potassium-dextran solution (50 mL/kg) and transplanted after 3 hours of cold ischemia. The experimental protocol included a control group, a phentolamine group, in which donor lungs were infused with phentolamine (2 mg/kg), and a FK506 group, in which the animals received FK506 (25 mg/kg per hour) intravenously during reperfusion. After 4 hours of reperfusion, alveolar liquid clearance, wet-to-dry ratios, lung epithelial Na+ channel expression, and the response to β-adrenergic stimulation were measured.

Results: The increase in wet-to-dry ratios of transplanted lungs was less pronounced in the phentolamine and FK506 groups. The FK506 treatment led to improvement of alveolar liquid clearance. Neither phentolamine nor FK506 influenced lung epithelial Na+ channel expression in transplanted lungs or preserved alveolar cell ability to respond to β-adrenergic stimulation.

Conclusions: Phentolamine or FK506 treatment during reperfusion improves alveolar liquid clearance and decreases the severity of lung injury.


Related Article

Invited Commentary
Susan Moffatt-Bruce
Ann. Thorac. Surg. 2009 88: 964-965. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
S. Moffatt-Bruce
Invited commentary.
Ann. Thorac. Surg., September 1, 2009; 88(3): 964 - 965.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The Society of Thoracic Surgeons.